Genzyme Ceredase
Executive Summary
NDA filed for treatment of Type 1 Gaucher's disease, biotech firm reported April 23. The enzyme product has been available to patients since November 1989 under a Treatment IND. There are an estimated 10,000-20,000 cases of Gaucher's disease in the U.S.